45058 Federal Register / Vol. 72, No. 154 / Friday, August 10, 2007 / Notices 

Place: Miyako Hotel, 1625 Post Street, San 

Francisco, CA 94115. 

Contact Person: Suzanne L. ForrySchaudies, PhD, Scientific Review 

Administrator, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 6192, MSC 7804, Bethesda, MD 

20892, 301–451–0131, forryscs@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group, 

Integrative and Clinical Endocrinology and 

Reproduction Study Section. 

Date: September 26–27, 2007. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Michael Knecht, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6176, 

MSC 7892, Bethesda, MD 20892, 301–435–

1046, knechtm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, AcademicIndustrial Partnership for Cancer Imaging. 

Date: September 28, 2007. 

Time: 11 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Xiang-Ning Li, MD, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5112, 

MSC 7854, Bethesda, MD 20892, 301–435–

1744, lixiang@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 2, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–3898 Filed 8–9–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License: Method for Treating Strokes 

by Inducing Tolerance to E-Selectin 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: This is notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

404.7(a)(1)(i), that the National 

Institutes of Health (NIH), Department 

of Health and Human Services, is 

contemplating the grant of an exclusive 

license worldwide to practice the 

inventions embodied in: U.S. Patent 

Application Numbers 60/206,693 filed 

May 24, 2000, 10/296,423 filed 

November 22, 2002 and corresponding 

foreign applications entitled ‘‘Method 

for Preventing Strokes by Inducing 

Tolerance to E-Selectin’’ and U.S. Patent 

Application Numbers 60/828,732 filed 

October 9, 2006 and 60/905,741 filed 

March 8, 2007 entitled ‘‘Treatment and 

Prevention of Inflammation’’ to 

Novavax, Inc., having a place of 

business in Rockville, Maryland. The 

patent rights in these inventions have 

been assigned to the United States of 

America. 

The contemplated exclusive license 

may be limited to the use of E-selectin 

for the prevention or treatment of stroke. 

DATES: Only written comments and/or 

applications for a license which are 

received by the NIH Office of 

Technology Transfer on or before 

October 9, 2007 will be considered. 

ADDRESSES: Requests for a copy of the 

patent application, inquiries, comments 

and other materials relating to the 

contemplated license should be directed 

to: Norbert J. Pontzer, J.D., PhD, 

Technology Licensing Specialist, Office 

of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, MD 

20852–3804; Telephone: (301) 435–

5502; Facsimile: (301) 402–0220, E-mail: 

pontzern@mail.nih.gov. A signed 

Confidential Disclosure Agreement will 

be required to receive copies of the 

patent application if not yet published. 

SUPPLEMENTARY INFORMATION: This 

invention provides methods of treating 

or preventing brain damage in stroke 

through administration of E-selectin, an 

inducible adhesion molecule on 

endothelial cells. The expression of 

E-selectin is induced on human 

endothelium in response to activation 

by cytokines IL–1 and TNF. E-selectin 

mediates the adhesion of various 

leukocytes, including neutrophils, 

monocytes, eosinophils, natural killer 

cells, and a subset of T cells to activated 

endothelium. Activation of vascular 

endothelial cells by proinflammatory 

cytokines is believed to be involved in 

conversion of the luminal surface of 

endothelium from anticoagulant and 

anti-inflammatory to procoagulant and 

pro-inflammatory leading to thrombosis. 

Segmental vascular activation and 

thrombosis are involved in the 

development of strokes. 

The prospective exclusive license will 

be royalty-bearing and will comply with 

the terms and conditions of 35 U.S.C. 

209 and 37 CFR 404.7. The prospective 

exclusive license may be granted unless, 

within 60 days from the date of this 

published Notice, NIH receives written 

evidence and argument that establishes 

that the grant of the license would not 

be consistent with the requirements of 

35 U.S.C. 209 and 37 CFR 404.7. 

Properly filed competing applications 

for a license filed in response to this 

notice will be treated as objections to 

the contemplated license. Comments 

and objections submitted in response to 

this notice will not be made available 

for public inspection, and, to the extent 

permitted by law, will not be released 

under the Freedom of Information Act, 

5 U.S.C. 552. 

Dated: August 3, 2007. 

Steven M. Ferguson, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. E7–15621 Filed 8–9–07; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Musculoskeletal Rehabilitation. 

Date: August 16, 2007. 

Time: 2 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Jo Pelham, BA, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 4102, MSC 7814, 

Bethesda, MD 20892, (301) 435–1786, 

pelhamj@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 


sroberts on PROD1PC70 with PROPOSALS
Federal Register / Vol. 72, No. 154 / Friday, August 10, 2007 / Notices 45059 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 3, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–3904 Filed 8–9–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–5125–N–32] 

Federal Property Suitable as Facilities 

To Assist the Homeless 

AGENCY: Office of the Assistant 

Secretary for Community Planning and 

Development, HUD. 

ACTION: Notice. 

SUMMARY: This Notice identifies 

unutilized, underutilized, excess, and 

surplus Federal property reviewed by 

HUD for suitability for possible use to 

assist the homeless. 

DATES: Effective Date: August 10, 2007. 

FOR FURTHER INFORMATION CONTACT: 

Kathy Ezzell, Department of Housing 

and Urban Development, Room 7262, 

451 Seventh Street, SW., Washington, 

DC 20410; telephone (202) 708–1234; 

TTY number for the hearing- and 

speech-impaired (202) 708–2565, (these 

telephone numbers are not toll-free), or 

call the toll-free Title V information line 

at 1–800–927–7588. 

SUPPLEMENTARY INFORMATION: In 

accordance with the December 12, 1988 

court order in National Coalition for the 

Homeless v. Veterans Administration, 

No. 88–2503–OG (D.D.C.), HUD 

publishes a Notice, on a weekly basis, 

identifying unutilized, underutilized, 

excess and surplus Federal buildings 

and real property that HUD has 

reviewed for suitability for use to assist 

the homeless. Today’s Notice is for the 

purpose of announcing that no 

additional properties have been 

determined suitable or unsuitable this 

week. 

Dated: August 2, 2007. 

Mark R. Johnston, 

Deputy Assistant Secretary for Special Needs. 

[FR Doc. 07–3842 Filed 8–9–07; 8:45 am] 

BILLING CODE 4210–67–M 

DEPARTMENT OF THE INTERIOR 

Office of the Secretary 

Exxon Valdez Oil Spill Trustee Council; 

Notice of Meeting 

AGENCY: Office of the Secretary, 

Department of the Interior. 

ACTION: Notice of meeting. 

SUMMARY: The Department of the 

Interior, Office of the Secretary is 

announcing a public meeting of the 

Exxon Valdez Oil Spill Public Advisory 

Committee. 

DATES: August 30, 2007, at 9 a.m. 

ADDRESSES: Exxon Valdez Oil Spill 

Trustee Council Office, 441 West 5th 

Avenue, Suite 500, Anchorage, Alaska. 

FOR FURTHER INFORMATION CONTACT: 

Douglas Mutter, Department of the 

Interior, Office of Environmental Policy 

and Compliance, 1689 C Street, Suite 

119, Anchorage, Alaska 99501, (907) 

271–5011. 

SUPPLEMENTARY INFORMATION: The 

Public Advisory Committee was created 

by Paragraph V.A.4 of the Memorandum 

of Agreement and Consent Decree 

entered into by the United States of 

America and the State of Alaska on 

August 27, 1991, and approved by the 

United States District Court for the 

District of Alaska in settlement of 

United States of America v. State of 

Alaska, Civil Action No. A91–081 CV. 

The meeting agenda will include review 

of proposed work plan amendments and 

discussions about outreach and 

education activities and habitat 

protection. 

Willie R. Taylor, 

Director, Office of Environmental Policy and 

Compliance. 

[FR Doc. E7–15727 Filed 8–9–07; 8:45 am] 

BILLING CODE 4310–RG–P 

DEPARTMENT OF THE INTERIOR 

Fish and Wildlife Service 

Notice of Intent To Prepare a 

Comprehensive Conservation Plan and 

Environmental Assessment; Trinity 

River National Wildlife Refuge, Located 

in Liberty County, TX 

AGENCY: Fish and Wildlife Service, 

Interior. 

SUMMARY: This notice advises the public 

that the Fish and Wildlife Service, 

Southwest Region, intends to gather 

information necessary to prepare a CCP 

and EA for Trinity River National 

Wildlife Refuge (Refuge), pursuant to 

the National Environmental Policy Act 

and its implementing regulations. The 

Service is furnishing this notice in 

compliance with the National Wildlife 

Refuge System Administration Act of 

1966, to achieve the following: 

(1) Advise other agencies and the 

public of our intentions, and 

(2) Obtain suggestions and 

information on the scope of issues to 

include in the environmental document. 

DATES: Special mailings, newspaper 

articles, postings, and media 

announcements will inform people of 

opportunities for written input 

throughout the CCP planning process. 

Refuge fact sheets will be made 

available at local libraries in the 

surrounding communities. This notice 

of intent/public scoping process will 

continue until November 30, 2007. 

Written comments submitted by mail or 

e-mail should be postmarked by that 

date to ensure consideration. Comments 

mailed after that date will be considered 

to the extent practical. Inquire at the 

following address for future dates of 

planning activities and due dates for 

comments. 

ADDRESSES: Address comments and 

requests for more information to: Stuart 

Marcus, Refuge Manager, Trinity River 

National Wildlife Refuge, P.O. Box 

10015, Liberty, Texas 77575; phone: 

936–336–9786, fax: 936–336–9847. 

Information concerning this Refuge may 

also be found at the following Web site: 

http://southwest.fws.gov. Comments 

submitted via e-mail should be 

addressed to Yvette Truitt-Ortiz at 

Yvette_TruittOrtiz@fws.gov or 

Stuart_Marcus@fws.gov. Additionally, 

you may hand-deliver comments to Mr. 

Marcus at the Refuge, located 

approximately 48 miles east of Houston, 

Texas and 44 miles west of Beaumont, 

Texas on Highway 90. Our practice is to 

make comments, including names and 

addresses of respondents, available for 

public review during regular business 

hours. Individual respondents may 

request that we withhold their home 

address from the rulemaking record, 

which we will honor to the extent 

allowable by law. 

FOR FURTHER INFORMATION CONTACT: 

Yvette Truitt-Ortiz, Natural Resource 

Planner, Division of Planning, P.O. Box 

1306, Albuquerque, New Mexico 

87103–1306; phone: 505–248–6452; fax 

505–248–6874; e-mail 

Yvette_TruittOrtiz@fws.gov. 

SUPPLEMENTARY INFORMATION: The 

National Wildlife Refuge System 

Improvement Act of 1997 requires that 

all lands within the National Wildlife 

Refuge System (NWRS) are to be 

managed in accordance with an 

approved CCP. The CCP guides 


sroberts on PROD1PC70 with PROPOSALS